By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – MolecularHealth today said that it has signed a five-year deal with the US Food and Drug Administration to evaluate and refine the firm's software system for mechanism-based drug safety assessment and prediction.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Science this week: new chromatin imaging approach, and more.
University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.
Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.
Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.